Precision BioSciences, Inc. (DTIL)
7.27
-0.84
(-10.36%)
USD |
NASDAQ |
May 15, 16:00
7.31
+0.04
(+0.55%)
After-Hours: 20:00
Precision BioSciences Total Liabilities (Quarterly) : 67.79M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 945.71M |
| Cartesian Therapeutics, Inc. | 436.51M |
| AnaptysBio, Inc. | 316.94M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 143.89M |
| Shareholders Equity (Quarterly) | 76.10M |
| Debt to Equity Ratio | 0.3741 |
| Current Ratio | 14.02 |
| Net Debt Paydown Yield | 0.22% |